American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
Upgrade
American Flag

PTC Therapeutics, Inc.

PTCT Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

Chart provided by TradingView

PTCT historical prices
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Congress Trading

Recent trades of PTCT by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
PTCT Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
PTCT Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
PTCT Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes in PTCT holdings by institutional investors

Insider Trading

Quarterly net insider trading by PTCT's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
View Strategy Copytrade Strategy
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

See Pricing
schema-2
Corporate Lobbying

Government lobbying spending instances

  • $170,000 Jul 20, 2026 Issue: Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $390,000 Apr 20, 2026 Issue: Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $140,000 Jan 20, 2026 Issue: Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid Taxation/Internal Revenue Code
  • $140,000 Oct 20, 2025 Issue: Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid Taxation/Internal Revenue Code
  • $120,000 Jul 21, 2025 Issue: Taxation/Internal Revenue Code Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid
  • $210,000 Apr 21, 2025 Issue: Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid Taxation/Internal Revenue Code
  • $80,000 Feb 04, 2025 Issue: Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid Taxation/Internal Revenue Code
  • $90,000 Feb 04, 2025 Issue: Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid Taxation/Internal Revenue Code
  • $90,000 Feb 04, 2025 Issue: Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid Taxation/Internal Revenue Code
  • $500,000 Feb 04, 2025 Issue: Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid Taxation/Internal Revenue Code
  • $170,000 Feb 04, 2025 Issue: Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid Taxation/Internal Revenue Code Budget/Appropriations
  • $170,000 Feb 04, 2025 Issue: Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid Taxation/Internal Revenue Code Budget/Appropriations
  • $190,000 Feb 04, 2025 Issue: Taxation/Internal Revenue Code Budget/Appropriations Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid
  • $570,000 Feb 04, 2025 Issue: Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid Taxation/Internal Revenue Code
  • $160,000 Jan 20, 2023 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Medical/Disease Research/Clinical Labs Health Issues
  • $190,000 Oct 20, 2022 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Medical/Disease Research/Clinical Labs Health Issues
  • $200,000 Jul 20, 2022 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs Health Issues
  • $370,000 Apr 20, 2022 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs Health Issues
  • $190,000 Apr 20, 2022 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs Health Issues
  • $180,000 Oct 20, 2021 Issue: None
  • $180,000 Jul 20, 2021 Issue: None
  • $180,000 Apr 20, 2021 Issue: None
  • $180,000 Jan 21, 2021 Issue: None
  • $180,000 Oct 29, 2020 Issue: None
  • $50,000 Jul 20, 2020 Issue: Health Issues
  • $50,000 Apr 26, 2020 Issue: Health Issues
  • $50,000 Feb 25, 2020 Issue: Health Issues
  • $20,000 Apr 17, 2019 Issue: Budget/Appropriations
  • $40,000 Apr 17, 2019 Issue: Budget/Appropriations
  • $30,000 Jan 22, 2019 Issue: Budget/Appropriations
  • $60,000 Jan 22, 2019 Issue: Budget/Appropriations
  • $10,000 Jan 16, 2019 Issue: None
  • $10,000 Oct 18, 2018 Issue: Health Issues Medicare/Medicaid
  • $30,000 Oct 18, 2018 Issue: Budget/Appropriations
  • $60,000 Oct 18, 2018 Issue: Budget/Appropriations
  • $30,000 Jul 20, 2018 Issue: Budget/Appropriations
  • $60,000 Jul 20, 2018 Issue: Budget/Appropriations
  • $30,000 Apr 20, 2018 Issue: Budget/Appropriations
  • $30,000 Apr 20, 2018 Issue: Budget/Appropriations
  • $30,000 Jan 17, 2018 Issue: Budget/Appropriations
  • $30,000 Jan 17, 2018 Issue: Budget/Appropriations
  • $30,000 Oct 18, 2017 Issue: Budget/Appropriations
  • $30,000 Oct 18, 2017 Issue: Budget/Appropriations
  • $30,000 Aug 09, 2017 Issue: Budget/Appropriations
  • $30,000 Aug 09, 2017 Issue: Budget/Appropriations
  • $30,000 Jul 18, 2017 Issue: Budget/Appropriations
  • $10,000 Apr 20, 2017 Issue: Health Issues
  • $30,000 Apr 19, 2017 Issue: Budget/Appropriations
  • $10,000 Jan 19, 2017 Issue: Budget/Appropriations
  • $30,000 Jan 12, 2017 Issue: Budget/Appropriations
  • $30,000 Oct 20, 2016 Issue: Health Issues
Revolving Door

Former government officials who have lobbied for PTCT

23 former government officials from 17 congressional offices at 6 lobbying firms have lobbied for PTCT, most recently Jul 20, 2026.

  • Elizabeth Warren
    Remy Mason Senate Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson Schwartz Formerly with Elizabeth Warren · BGR GOVERNMENT AFFAIRS · Jul 20, 2026
  • John Stone House Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, Health Subcommittee; Intern, House E&C Formerly Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, · BGR GOVERNMENT AFFAIRS · Jul 20, 2026
  • Brent Del Monte Other See prior filing Formerly See prior filing · BGR GOVERNMENT AFFAIRS · Jul 20, 2026
  • Bill Cassidy
    Robb Walton Senate Senior Health Policy Advisor and Counsel Sen Cassidy; Advisor Rep. Cassidy; Research Asst., Staff Asst., Intern on Senate HELP, Ranking Member, Sen. Enzi; Intern to Rep. Nunes Formerly with Bill Cassidy · BGR GOVERNMENT AFFAIRS · Jul 20, 2026
  • Debbie Wasserman Schultz
    Daniel Farmer House Intern, Staff Asst, Leg. Corr./Leg. Asst. for Rep. Debbie Wasserman Schultz; Leg. Asst., Sr. Leg. Asst., Leg. Dir. for Zack Space Formerly with Debbie Wasserman Schultz · BGR GOVERNMENT AFFAIRS · Jul 20, 2026
  • Jimmy Panetta
    Joel Bailey House COS Rep. Panetta; LD Rep. Ashford; LD Rep. Matheson; Sr. LA Rep. Matsui; LA, Sr. LA Rep. Baron Hill; Intern Rep. Rahall Formerly with Jimmy Panetta · BGR GOVERNMENT AFFAIRS · Jul 20, 2026
  • Jon C. Porter
    Alanna Temme House Legislative Director, U.S. Representative Jon Porter Formerly with Jon C. Porter · LMH STRATEGIC SOLUTIONS · Jul 05, 2026
  • Martha Roby
    Sophie Khanahmadi House Legislative Asst., Rep. Martha Roby; Legislative Asst., Rep. Lee Terry; Staff Asst./LC, Senator Jeff Sessions Formerly with Martha Roby · LMH STRATEGIC SOLUTIONS · Jul 05, 2026
See all 23 on the Revolving Door dashboard
Corporate Lobbying

PTCT Estimated quarterly lobbying spending

Revenue Breakdown

PTCT Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
PTCT Income Statement
PTCT Balance Sheet
PTCT Cash Flow
U.S. Patents

New PTCT patent grants

  • Patent Title: Compounds for treating spinal muscular atrophy Nov. 05, 2019
  • Patent Title: Substituted triazine bmi-1 inhibitors May. 22, 2018
  • Patent Title: Compounds for treating spinal muscular atrophy Mar. 13, 2018
  • Patent Title: Compounds for treating spinal muscular atrophy Jan. 30, 2018
  • Patent Title: Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy Jan. 30, 2018
  • Patent Title: Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid Jan. 23, 2018
  • Patent Title: Compositions of 1,2,4-oxadiazole benzoic acid compounds and methods for their use Jan. 09, 2018
  • Patent Title: Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy Aug. 22, 2017
  • Patent Title: Antibacterial compounds and methods for use May. 16, 2017
  • Patent Title: Compounds for treating spinal muscular atrophy Apr. 11, 2017
  • Patent Title: 1,3,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease Apr. 04, 2017
  • Patent Title: Compounds and methods for antiviral treatment Mar. 14, 2017
  • Patent Title: Compounds for treating spinal muscular atrophy Mar. 07, 2017
  • Patent Title: Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy Dec. 20, 2016
  • Patent Title: Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same Nov. 15, 2016
  • Patent Title: Methods and agents for screening for compounds capable of modulating gene expression Oct. 25, 2016
  • Patent Title: Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease Oct. 25, 2016
  • Patent Title: Antibacterial compounds and methods for use Aug. 09, 2016
  • Patent Title: Compounds for treating spinal muscular atrophy Jul. 26, 2016
  • Patent Title: Survival motor neuron gene (smn2) mrna constructs for post-transcription regulation Jul. 19, 2016
  • Patent Title: Methods of screening for compounds for treating muscular dystrophy using human alpha7 integrin mrna translation regulation Jun. 28, 2016
  • Patent Title: Compounds for treating spinal muscular atrophy Jun. 21, 2016
  • Patent Title: Methods for treating cancer and non-neoplastic conditions May. 31, 2016
  • Patent Title: Compounds for nonsense suppression, and methods for their use Apr. 19, 2016
  • Patent Title: Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4] oxadiazol-3-yl]-benzoic acid Apr. 12, 2016
  • Patent Title: Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associated therewith Mar. 22, 2016
  • Patent Title: Compounds for nonsense suppression, and methods for their use Mar. 01, 2016
  • Patent Title: Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control Mar. 01, 2016
  • Patent Title: Methods for dosing an orally active 1,2,4-oxadiazole Jan. 05, 2016
  • Patent Title: Compositions of 1,2,4-oxadiazol benzoic acid compounds and methods for their use Dec. 08, 2015
  • Patent Title: Combinations of a hcv inhibitor such as bicyclic pyrrole derivatives and a therapeutic agent Dec. 01, 2015
  • Patent Title: Cell based methods and systems for the identification of rna regulatory sequences and compounds that modulate their functions Jun. 30, 2015
  • Patent Title: Methods and agents for screening for compounds capable of modulating gene expression Jun. 30, 2015
  • Patent Title: Pyrazole or triazole compounds and their use for the manufacture of a medicament for treating somatic mutation related diseases Jun. 09, 2015
  • Patent Title: Methods for treating spinal muscular atrophy Mar. 24, 2015
  • Patent Title: Methods for using 1,2,4-oxadiazole benzoic acid compounds Mar. 10, 2015
  • Patent Title: Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control Feb. 03, 2015
  • Patent Title: Tetra-cyclic carboline derivatives useful in the inhibition of angiogenesis Jan. 27, 2015
  • Patent Title: Screening assays for compounds that modulate programmed ribosomal frameshifting Jan. 13, 2015
  • Patent Title: Hcv inhibitor and therapeutic agent combinations Sep. 23, 2014
  • Patent Title: Methods for using 1,2,4-oxadiazole benzoic acid compounds Aug. 05, 2014
  • Patent Title: Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid Jun. 10, 2014
  • Patent Title: Methods of screening for compounds for treating muscular dystrophy using migf1 mrna translation regulation Jun. 03, 2014
  • Patent Title: Indole derivatives and methods for antiviral treatment May. 27, 2014
  • Patent Title: Methods for dosing an orally active 1,2,4-oxadiazole May. 06, 2014
  • Patent Title: Compounds for nonsense suppression and methods for their use Apr. 29, 2014
  • Patent Title: Methods for treating prostate conditions Apr. 22, 2014
  • Patent Title: Methods for treating kaposi sarcoma Apr. 15, 2014
  • Patent Title: Hydroxylated 1,2,4-oxadiazole benzoic acid compounds, compositions thereof and their use in bioassays Apr. 08, 2014
  • Patent Title: Bmi-1 protein expression modulators Mar. 25, 2014
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded to PTCT from public contracts

PTCT News

Recent insights relating to PTCT

CNBC Recommendations

Recent picks made for PTCT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in PTCT

PTCT Analyst Ratings

PTCT Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
PTCT Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $PTCT stock a Buy, Sell, or Hold?

  • What is the price target for $PTCT stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

PTCT Top Shareholders
Shareholder
Shares Held
PTCT Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $PTCT stock?

  • Who owns the most shares of $PTCT stock?

  • What funds own $PTCT stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

PTCT Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view PTCT Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About PTCT

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

  • Address Warren, NJ
  • Market Cap 5.5 billion
  • Employees 991
  • Industrial Classification Pharmaceutical Preparations

PTC Therapeutics, Inc. (PTCT) Historical Stock Prices

PTC Therapeutics, Inc. (PTCT) closed at $65.96 on September 22, 2026. Over the past year its adjusted close ranged from $57.84 to $89.55. Daily prices go back to January 2, 2014, 3,198 trading days in all.

  • 1 month-5.53%
  • 3 months-19.69%
  • Year to date-13.16%
  • 1 year+8.40%
  • 3 years+175.75%
  • 5 years+67.07%
  • Max+294.03%
See every congressional and insider trade on the PTCT price chart

Quiver Premium charts PTCT's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 22, 2026 66.24 66.58 65.36 65.96 65.96 1,307,235
Sep 21, 2026 65.93 66.21 64.99 65.26 65.26 1,086,197
Sep 18, 2026 68.00 68.00 65.18 65.37 65.37 3,864,989
Sep 17, 2026 68.84 68.84 67.22 68.00 68.00 1,115,270
Sep 16, 2026 65.99 67.90 65.80 67.59 67.59 1,397,906
Sep 15, 2026 66.51 66.54 65.06 65.65 65.65 1,034,204
Sep 14, 2026 67.09 67.99 65.91 66.48 66.48 1,018,796
Sep 11, 2026 67.80 68.48 65.91 66.06 66.06 792,889
Sep 10, 2026 66.84 67.78 66.47 67.37 67.37 1,013,224
Sep 9, 2026 68.08 68.84 67.50 67.57 67.57 1,066,522
Sep 8, 2026 67.81 70.08 67.47 68.81 68.81 1,118,323
Sep 4, 2026 70.62 71.41 69.26 69.30 69.30 673,539
Sep 3, 2026 71.76 71.97 70.55 71.40 71.40 654,521
Sep 2, 2026 71.15 72.68 69.83 71.79 71.79 902,584
Sep 1, 2026 69.42 70.84 69.05 70.56 70.56 691,015
Aug 31, 2026 69.98 70.42 68.75 69.54 69.54 841,097
Aug 28, 2026 71.08 71.49 69.61 70.09 70.09 692,675
Aug 27, 2026 72.11 72.66 70.91 71.81 71.81 746,330
Aug 26, 2026 73.18 73.53 71.81 72.69 72.69 533,667
Aug 25, 2026 71.69 73.47 71.69 73.47 73.47 624,463
Aug 24, 2026 69.67 71.45 68.02 71.06 71.06 897,681
Aug 21, 2026 70.54 71.36 69.79 69.82 69.82 674,738
Aug 20, 2026 73.05 73.56 70.46 70.52 70.52 802,507
Aug 19, 2026 73.72 74.02 72.22 73.67 73.67 1,514,567
Aug 18, 2026 72.86 74.03 72.22 72.63 72.63 731,633
Aug 17, 2026 71.70 73.02 71.25 72.88 72.88 985,768
Aug 14, 2026 71.58 72.13 70.85 71.70 71.70 564,330
Aug 13, 2026 73.14 73.33 71.69 71.97 71.97 697,348
Aug 12, 2026 73.23 74.22 72.18 72.64 72.64 976,043
Aug 11, 2026 75.00 75.00 72.86 73.70 73.70 763,594
Aug 10, 2026 72.77 74.75 72.47 74.63 74.63 826,179
Aug 7, 2026 71.71 73.37 70.95 73.31 73.31 963,179
Aug 6, 2026 68.99 71.04 68.99 70.85 70.85 928,898
Aug 5, 2026 69.21 70.19 68.50 69.21 69.21 1,102,512
Aug 4, 2026 69.27 69.80 67.51 69.10 69.10 1,420,925
Aug 3, 2026 67.18 68.73 66.07 68.11 68.11 1,367,720
Jul 31, 2026 70.92 73.72 64.57 68.01 68.01 4,329,705
Jul 30, 2026 73.39 76.18 73.39 75.52 75.52 1,374,880
Jul 29, 2026 74.85 76.46 73.61 74.49 74.49 1,173,858
Jul 28, 2026 75.64 76.17 72.61 75.39 75.39 1,487,692
Jul 27, 2026 77.62 79.33 75.72 75.80 75.80 1,852,688
Jul 24, 2026 79.33 79.40 76.59 76.82 76.82 838,164
Jul 23, 2026 77.45 79.53 77.27 78.45 78.45 759,373
Jul 22, 2026 77.58 79.53 77.22 78.40 78.40 583,883
Jul 21, 2026 79.50 80.56 77.53 78.50 78.50 1,145,977
Jul 20, 2026 78.78 79.70 77.42 78.01 78.01 954,314
Jul 17, 2026 77.52 79.41 77.47 78.59 78.59 704,130
Jul 16, 2026 79.62 80.22 77.86 78.52 78.52 1,888,995
Jul 15, 2026 77.54 78.85 76.55 78.84 78.84 1,357,110
Jul 14, 2026 80.41 81.31 77.91 78.06 78.06 1,619,044
Jul 13, 2026 83.24 83.67 80.69 81.33 81.33 985,956
Jul 10, 2026 89.71 89.71 83.83 84.85 84.85 1,066,837
Jul 9, 2026 89.01 90.87 85.40 89.55 89.55 1,269,804
Jul 8, 2026 87.90 89.85 85.60 88.57 88.57 1,328,349
Jul 7, 2026 86.84 89.80 84.76 89.20 89.20 1,410,794
Jul 6, 2026 84.14 87.07 82.70 85.44 85.44 3,806,833
Jul 2, 2026 81.27 83.37 80.77 83.31 83.31 6,778,019
Jul 1, 2026 82.50 82.78 81.00 81.35 81.35 1,221,573
Jun 30, 2026 81.97 83.22 80.68 81.57 81.57 2,375,631
Jun 29, 2026 83.55 84.37 80.21 81.57 81.57 4,294,986
Jun 26, 2026 84.69 85.83 83.25 84.43 84.43 3,903,105
Jun 25, 2026 85.10 87.03 83.94 84.51 84.51 1,986,569
Jun 24, 2026 82.99 85.15 81.81 84.41 84.41 3,320,510
Jun 23, 2026 81.05 83.05 80.30 82.13 82.13 2,307,236
Jun 22, 2026 80.00 81.71 79.50 80.96 80.96 2,414,051
Jun 18, 2026 79.58 80.00 78.10 78.98 78.98 2,870,286
Jun 17, 2026 75.56 79.60 74.86 78.53 78.53 3,183,591
Jun 16, 2026 75.40 76.95 72.04 73.27 73.27 6,044,172
Jun 15, 2026 72.03 77.13 71.80 76.77 76.77 3,590,710
Jun 12, 2026 74.71 75.93 74.36 75.14 75.14 1,074,606
Jun 11, 2026 73.40 75.51 72.66 74.71 74.71 2,245,458
Jun 10, 2026 73.63 75.09 72.72 73.35 73.35 1,211,358
Jun 9, 2026 73.14 74.29 71.30 73.68 73.68 1,873,819
Jun 8, 2026 70.96 71.91 69.74 70.87 70.87 1,293,398
Jun 5, 2026 70.78 72.97 69.92 70.97 70.97 937,081
Jun 4, 2026 69.54 71.73 69.45 70.64 70.64 1,098,008
Jun 3, 2026 68.07 69.35 67.51 68.68 68.68 1,124,864
Jun 2, 2026 72.76 73.28 68.22 68.23 68.23 1,238,463
Jun 1, 2026 73.28 74.11 71.99 73.80 73.80 1,135,215
May 29, 2026 71.63 73.96 71.60 73.85 73.85 1,211,040
May 28, 2026 70.57 71.89 68.84 71.05 71.05 725,128
May 27, 2026 69.99 72.06 69.23 70.66 70.66 1,692,468
May 26, 2026 68.86 69.23 67.17 67.65 67.65 1,003,610
May 22, 2026 69.59 70.74 68.26 68.81 68.81 715,145
May 21, 2026 70.23 70.65 69.47 69.79 69.79 808,901
May 20, 2026 70.67 72.00 70.47 71.02 71.02 1,093,438
May 19, 2026 70.41 71.18 69.43 70.31 70.31 725,215
May 18, 2026 71.45 72.13 69.81 70.15 70.15 833,986
May 15, 2026 72.45 73.14 71.34 71.47 71.47 843,493
May 14, 2026 73.88 74.23 71.45 72.72 72.72 591,006
May 13, 2026 75.00 75.00 72.10 73.46 73.46 1,240,522
May 12, 2026 76.87 76.87 74.14 75.02 75.02 2,212,245
May 11, 2026 74.88 77.93 73.69 76.85 76.85 3,208,949
May 8, 2026 74.07 79.91 69.42 73.69 73.69 5,836,405
May 7, 2026 66.09 66.34 64.24 64.49 64.49 1,235,286
May 6, 2026 65.98 66.83 65.44 66.57 66.57 637,933
May 5, 2026 65.84 66.08 64.27 65.04 65.04 740,427
May 4, 2026 65.21 66.27 63.59 65.49 65.49 1,216,005
May 1, 2026 65.08 67.34 63.18 65.15 65.15 1,323,736
Apr 30, 2026 64.79 65.85 64.18 65.06 65.06 1,171,505
Apr 29, 2026 69.05 69.18 63.66 64.55 64.55 4,238,876
Apr 28, 2026 69.96 70.58 66.34 70.26 70.26 1,931,019
Apr 27, 2026 67.89 71.08 67.89 69.22 69.22 1,058,552
Apr 24, 2026 68.55 69.52 67.42 68.23 68.23 640,472
Apr 23, 2026 70.79 71.00 68.52 68.59 68.59 657,409
Apr 22, 2026 71.10 71.56 69.75 70.85 70.85 514,206
Apr 21, 2026 72.32 72.33 69.79 70.63 70.63 724,289
Apr 20, 2026 72.00 72.68 70.49 72.32 72.32 956,874
Apr 17, 2026 73.35 73.44 71.33 72.43 72.43 1,500,485
Apr 16, 2026 72.98 73.53 70.89 71.70 71.70 1,171,066
Apr 15, 2026 73.15 73.69 72.20 73.57 73.57 568,799
Apr 14, 2026 70.38 73.79 70.20 73.01 73.01 1,400,698
Apr 13, 2026 68.82 70.78 68.35 70.42 70.42 665,686
Apr 10, 2026 71.57 71.57 68.22 68.69 68.69 587,617
Apr 9, 2026 71.02 71.67 70.44 70.85 70.85 1,041,166
Apr 8, 2026 71.09 72.24 70.08 71.26 71.26 907,063
Apr 7, 2026 68.91 69.72 68.43 69.58 69.58 666,638
Apr 6, 2026 67.77 70.24 67.77 68.90 68.90 770,402
Apr 2, 2026 67.32 68.70 67.04 67.77 67.77 483,034
Apr 1, 2026 68.55 70.39 68.16 68.75 68.75 1,044,730
Mar 31, 2026 66.92 69.03 66.33 68.13 68.13 830,308
Mar 30, 2026 65.34 66.28 64.37 65.64 65.64 930,030
Mar 27, 2026 67.43 67.60 65.80 66.13 66.13 1,036,545
Mar 26, 2026 65.85 67.85 65.75 67.00 67.00 659,288
Mar 25, 2026 65.24 67.45 64.88 66.75 66.75 684,786
Mar 24, 2026 64.78 65.28 64.00 64.54 64.54 1,164,632
Mar 23, 2026 66.79 69.02 65.94 66.42 66.42 1,055,042
Mar 20, 2026 68.00 68.19 65.10 65.30 65.30 2,016,888
Mar 19, 2026 67.00 67.59 65.26 67.08 67.08 895,564
Mar 18, 2026 66.96 67.62 65.57 67.00 67.00 1,699,043
Mar 17, 2026 67.10 68.87 66.75 67.45 67.45 1,445,086
Mar 16, 2026 64.78 67.17 64.70 66.71 66.71 1,205,684
Mar 13, 2026 63.91 65.78 63.80 64.49 64.49 605,687
Mar 12, 2026 64.70 64.72 62.13 63.36 63.36 1,050,445
Mar 11, 2026 67.91 68.12 64.85 65.67 65.67 905,690
Mar 10, 2026 68.41 71.00 67.97 68.56 68.56 1,025,110
Mar 9, 2026 63.19 69.17 63.14 68.40 68.40 2,494,745
Mar 6, 2026 62.41 63.00 61.43 62.82 62.82 1,225,424
Mar 5, 2026 63.38 64.50 62.21 63.33 63.33 1,137,040
Mar 4, 2026 65.10 65.62 63.50 64.29 64.29 1,246,659
Mar 3, 2026 65.36 67.07 63.49 64.39 64.39 1,312,066
Mar 2, 2026 67.08 68.44 64.70 66.37 66.37 1,949,490
Feb 27, 2026 67.65 69.43 67.28 68.19 68.19 852,231
Feb 26, 2026 67.46 68.39 66.47 68.10 68.10 1,428,597
Feb 25, 2026 68.91 69.59 66.42 67.76 67.76 1,141,157
Feb 24, 2026 70.49 71.38 68.45 68.98 68.98 1,164,185
Feb 23, 2026 69.98 72.54 69.03 70.50 70.50 1,444,030
Feb 20, 2026 68.45 72.28 64.67 70.66 70.66 2,532,105
Feb 19, 2026 68.57 70.38 67.84 69.90 69.90 976,267
Feb 18, 2026 69.01 70.24 68.65 68.93 68.93 1,066,427
Feb 17, 2026 69.14 70.53 68.30 69.17 69.17 831,088
Feb 13, 2026 70.95 72.00 69.30 69.45 69.45 851,776
Feb 12, 2026 71.19 71.92 69.96 70.70 70.70 847,469
Feb 11, 2026 72.00 72.12 69.75 70.92 70.92 864,710
Feb 10, 2026 74.11 74.58 71.82 72.14 72.14 1,415,874
Feb 9, 2026 74.50 74.98 72.83 74.16 74.16 980,650
Feb 6, 2026 73.77 75.00 72.64 74.68 74.68 1,040,462
Feb 5, 2026 73.79 75.64 71.35 72.36 72.36 1,329,281
Feb 4, 2026 74.93 75.78 72.99 73.91 73.91 1,048,712
Feb 3, 2026 75.48 76.99 74.57 74.83 74.83 899,937
Feb 2, 2026 75.14 76.42 73.33 74.88 74.88 1,562,987
Jan 30, 2026 76.46 77.59 74.68 75.53 75.53 1,439,095
Jan 29, 2026 76.51 78.16 75.61 76.43 76.43 1,177,406
Jan 28, 2026 76.87 78.38 75.31 75.60 75.60 1,418,355
Jan 27, 2026 76.06 77.09 74.90 75.49 75.49 631,478
Jan 26, 2026 74.44 77.07 73.77 76.23 76.23 734,358
Jan 23, 2026 75.44 77.55 74.05 75.25 75.25 882,213
Jan 22, 2026 75.43 77.35 74.29 76.17 76.17 887,900
Jan 21, 2026 73.19 76.39 72.56 75.56 75.56 1,368,593
Jan 20, 2026 71.19 73.09 69.81 73.07 73.07 1,304,123
Jan 16, 2026 75.90 75.90 72.41 72.48 72.48 1,044,061
Jan 15, 2026 77.29 77.87 75.40 75.64 75.64 591,384
Jan 14, 2026 74.82 77.34 73.32 77.29 77.29 1,136,938
Jan 13, 2026 76.73 80.18 75.30 75.40 75.40 2,390,979
Jan 12, 2026 77.29 78.98 71.15 77.59 77.59 2,639,215
Jan 9, 2026 77.83 79.87 77.02 77.53 77.53 1,568,159
Jan 8, 2026 76.19 77.39 75.64 76.85 76.85 1,625,361
Jan 7, 2026 77.16 79.10 76.46 77.24 77.24 1,882,518
Jan 6, 2026 75.73 77.90 75.12 76.70 76.70 2,117,041
Jan 5, 2026 76.00 76.84 74.22 76.76 76.76 2,022,869
Jan 2, 2026 76.35 76.75 75.02 76.74 76.74 775,220
Dec 31, 2025 75.96 76.98 75.59 75.96 75.96 961,811
Dec 30, 2025 77.29 77.93 75.58 76.19 76.19 679,460
Dec 29, 2025 78.20 78.67 77.08 77.64 77.64 1,000,137
Dec 26, 2025 78.32 78.72 77.45 78.56 78.56 525,598
Dec 24, 2025 77.83 78.91 77.18 78.37 78.37 308,221
Dec 23, 2025 78.59 79.46 77.26 77.70 77.70 712,003
Dec 22, 2025 78.14 80.20 78.14 78.90 78.90 1,314,684
Dec 19, 2025 75.29 79.31 74.57 78.57 78.57 2,741,152
Dec 18, 2025 75.48 75.48 73.78 74.59 74.59 1,391,268
Dec 17, 2025 75.38 76.17 74.18 74.94 74.94 960,943
Dec 16, 2025 75.46 76.14 74.17 75.42 75.42 1,302,239
Dec 15, 2025 76.00 77.38 75.14 76.25 76.25 1,525,192
Dec 12, 2025 75.83 76.16 74.50 75.64 75.64 941,299
Dec 11, 2025 74.23 75.98 73.96 75.44 75.44 723,378
Dec 10, 2025 73.87 75.62 73.44 74.10 74.10 1,184,460
Dec 9, 2025 76.53 76.95 73.09 73.47 73.47 1,295,497
Dec 8, 2025 77.58 78.77 76.63 76.91 76.91 1,086,620
Dec 5, 2025 77.92 78.68 76.54 77.25 77.25 848,455
Dec 4, 2025 74.83 79.03 74.83 77.85 77.85 1,615,857
Dec 3, 2025 78.62 78.66 73.03 75.76 75.76 2,495,900
Dec 2, 2025 79.66 80.51 77.86 78.50 78.50 2,305,160
Dec 1, 2025 83.19 84.06 78.89 79.20 79.20 2,896,889
Nov 28, 2025 86.21 86.76 84.82 85.99 85.99 1,109,583
Nov 26, 2025 83.32 87.50 82.84 86.25 86.25 15,474,858
Nov 25, 2025 84.69 85.61 81.89 82.93 82.93 4,288,524
Nov 24, 2025 79.09 81.16 78.97 79.83 79.83 1,174,168
Nov 21, 2025 76.54 79.98 75.34 78.47 78.47 1,333,169
Nov 20, 2025 76.95 78.74 75.89 76.46 76.46 1,479,825
Nov 19, 2025 76.37 76.89 75.52 75.60 75.60 1,022,906
Nov 18, 2025 75.04 77.45 74.02 76.69 76.69 978,905
Nov 17, 2025 75.01 77.43 74.68 75.60 75.60 1,586,844
Nov 14, 2025 74.29 76.80 74.05 75.30 75.30 922,481
Nov 13, 2025 74.98 75.82 73.85 74.95 74.95 814,355
Nov 12, 2025 74.25 75.00 73.01 74.95 74.95 1,444,384
Nov 11, 2025 72.21 74.08 71.90 73.82 73.82 2,152,373
Nov 10, 2025 72.21 72.61 70.54 72.48 72.48 1,839,303
Nov 7, 2025 72.16 72.85 69.22 71.78 71.78 1,153,015
Nov 6, 2025 71.79 73.98 71.36 72.59 72.59 1,407,126
Nov 5, 2025 70.00 73.80 67.67 71.77 71.77 2,891,479
Nov 4, 2025 66.88 68.80 66.22 67.72 67.72 1,341,005
Nov 3, 2025 67.86 69.23 66.10 67.93 67.93 1,024,150
Oct 31, 2025 67.86 69.28 67.56 68.31 68.31 816,042
Oct 30, 2025 67.36 69.88 67.14 68.11 68.11 855,733
Oct 29, 2025 67.86 68.14 66.44 67.35 67.35 545,950
Oct 28, 2025 66.86 68.17 66.00 67.49 67.49 765,018
Oct 27, 2025 66.80 69.22 66.68 67.08 67.08 856,218
Oct 24, 2025 66.72 67.78 65.81 66.40 66.40 545,191
Oct 23, 2025 66.09 67.50 66.09 66.80 66.80 503,740
Oct 22, 2025 67.01 67.58 66.02 66.52 66.52 543,831
Oct 21, 2025 68.21 69.36 67.00 67.17 67.17 773,928
Oct 20, 2025 67.45 68.63 66.58 68.36 68.36 1,310,689
Oct 17, 2025 65.91 66.94 65.20 65.95 65.95 1,355,703
Oct 16, 2025 68.90 69.48 66.38 66.82 66.82 1,288,454
Oct 15, 2025 65.83 69.26 65.48 68.51 68.51 1,418,934
Oct 14, 2025 65.00 67.13 64.35 66.09 66.09 954,485
Oct 13, 2025 66.23 67.03 65.85 66.06 66.06 1,035,592
Oct 10, 2025 66.08 67.24 65.36 66.23 66.23 1,455,615
Oct 9, 2025 64.46 66.09 63.86 66.01 66.01 994,317
Oct 8, 2025 64.60 65.22 63.31 64.48 64.48 1,035,985
Oct 7, 2025 64.65 65.40 62.32 63.91 63.91 1,057,075
Oct 6, 2025 65.00 65.78 64.49 64.80 64.80 869,135
Oct 3, 2025 63.71 67.40 63.29 65.37 65.37 2,718,794
Oct 2, 2025 62.03 63.33 61.16 63.02 63.02 1,176,986
Oct 1, 2025 61.07 62.62 60.80 62.01 62.01 827,164
Sep 30, 2025 60.89 61.68 60.28 61.37 61.37 960,330
Sep 29, 2025 59.07 60.94 58.90 60.65 60.65 1,363,309
Sep 26, 2025 58.38 59.13 57.78 58.99 58.99 873,862
Sep 25, 2025 59.29 60.13 57.74 57.84 57.84 1,032,311
Sep 24, 2025 60.14 60.95 58.37 59.50 59.50 1,173,674
Sep 23, 2025 60.38 61.43 60.38 60.56 60.56 920,619
Sep 22, 2025 60.00 62.13 59.87 60.85 60.85 970,031

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
PTC Therapeutics, Inc. Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at PTCT, per a recent SEC DEF 14A filing. We estimate that the median employee at PTC THERAPEUTICS, INC. is paid $220,097.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation